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Shining'y--The intact wild-type mouse glucocorticoid receptor has a theoretical molecular 
weight of ~ 86 kDa based on amino acid sequence, but on SDS--polyacrylamide gel electro- 
phoresis it migrates as a protein of ~98 kDa. It is not known where the unusual primary 
structure or covalent modification responsible for this anomalous migration is located within 
the amino acid chain. In the course of examining the pattern of fragmentation of 32p-labeled 
glucocorticoid receptors from Chinese hamster ovary (CHO) cells containing amplified mouse 
receptor eDNA, we have found a localized region in the amino-terminal half of the receptor 
that accounts for this anomalous behavior. Cyanogen bromide treatment of the intact receptor 
produces a 23.4 kDa (theoretical) fragment consisting of residues 108-324 and containing all 
of the identified phosphorylated serines within the receptor. We find that the only large 
resolvable 3ZP-labeled receptor fragment produced after complete cyanogen bromide cleavage 
of intact receptors migrates with an apparent molecular weight of ~ 35 kDa. Because the 
apparent difference between the theoretical and the experimentally observed molecular weights 
of this cyanogen bromide fragment is essentially the same as the difference between the 
theoretical and experimental molecular weights of the intact mouse glucocorticoid receptor, 
we propose that some feature lying within this fragment accounts for slower migration. 
Although the existence of an additional phosphorylation site lying within the 15 kDa tryptic 
receptor fragment containing the DNA-binding domain has been contested, we also demon- 
strate that this fragment of the mouse glucocorticoid receptor is phosphorylated in vivo upon 
incubation of CHO cells in growth medium containing [32p]orthophosphate. 
INTRODUCTION 
When cDNAs for glucocorticoid receptors 
(GR) were cloned, it became apparent that 
significant discrepancies existed between their 
molecular weights predicted from sequence and 
their apparent Mr on SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE).  For  example, the 
human and rat G R  cDNAs encode proteins of  
777 and 795 amino acids, respectively, yet the 
Mr for both of  these ~ 86-87,000 Da proteins is 
~94  kDa on SDS-PAGE [1, 2]. The 783 amino 
acid mouse G R  [3] migrates with an Mr of  
~ 98 kDa on SDS-PAGE [4], and the basis for 
this ~ 12 kDa discrepancy is unknown. 
Such deviations from theoretical molecular 
weight have been explained for other proteins 
*To whom correspondence should be addressed. 
by the attachment of carbohydrate moieties, or 
by the acylation or phosphorylation of  amino 
acids, or by the presence of an highly unusual 
primary amino acid sequence within the 
polypeptide chain. Because the only known 
covalent modification of the mouse glucocorti- 
coid receptor [4-12], and indeed of  all steroid 
receptors (for review, see Ref. [13]), is phos- 
phorylation, one could presume that this might 
account for the Mr discrepancy. However, we 
have previously demonstrated that digestion of  
the mouse G R with calf intestine alkaline phos- 
phatase removes all but a trace amount of  the 
receptor phosphate without altering the appar- 
ent receptor Mr on SDS-PAGE (cf. Fig. 9 in 
Ref. [10]). Thus, the Mr discrepancy cannot be 
due to receptor phosphorylation. However, 
during the course of  such a study of  receptor 
phosphorylation, we have found that the 
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12 kDa Mr discrepancy is determined by a 
region in the transactivation domain of the 
mouse GR. 
In this work we have labeled mouse 
GR overexpressed in Chinese hamster ovary 
(CHO) cells by incubating cells with 
[32p]orthophosphate and have examined the 
pattern of fragmentation produced after 
exhaustive cyanogen bromide cleavage. The pre- 
dicted molecular weight for the largest receptor 
fragment produced by cyanogen bromide cleav- 
age (containing much of the transactivating 
domain) is 23.4 kDa, and it contains all of the 
phosphorylation sites thus far identified in the 
mouse receptor, representing 81% of the total 
32p recovered by Bodwell et al. [12]. Cyanogen 
bromide cleavage of 32p-labeled mouse GR re- 
veals a single resolvable 32p-labeled receptor 
fragment migrating at ,~ 35 kDa. As the appar- 
ent difference between the theoretical and exper- 
imentally observed molecular weights of the 
cyanogen bromide fragment is approximately 
the same as the difference between the theoreti- 
cal and observed molecular weights of the intact 
mouse GR, we propose that this region of the 
receptor determines the anomalous migration of 
the intact receptor on SDS-PAGE. 
EXPERIMENTAL 
Chemicals 
[32P]Orthophosphate (carrier free) was from 
Amersham Corp, and cyanogen bromide was 
from Pierce. Methotrexate, proline, TPCK- 
treated trypsin and TLCK-treated chymo- 
trypsin, TPCK, soybean trypsin inhibitor, 
protein A-Sepharose 4B, molecular weight 
markers, affinity-purified horseradish peroxi- 
dase conjugate of goat anti-mouse IgG, and 
phosphate-free and phosphate-containing Dul- 
becco's modified Eagle medium (high glucose) 
were from Sigma Chemical Co. BuGR2 anti-re- 
ceptor monoclonal antibody was from Affinity 
Bioreagents; nitrocellulose membranes were 
from Bio-Rad; Immobilon-P membranes were 
from Millipore; calf serum was from HyClone; 
and dialysed calf serum was from Gibco. 
Cell culture, 32p-labeling conditions and cytosol 
preparation 
The WCL2 line of CHO cells overexpressing 
the mouse GR was established by Hirst 
et al. [14] and the receptor expressed in this cell 
line has been described previously [15]. The cells 
were grown in monolayer culture using Dul- 
becco's modified Eagle medium plus 3#M 
methotrexate, 30 #g/ml proline and 10% iron- 
supplemented calf serum at 37°C. For 32p-label- 
ing experiments, cells in log phase of 
growth were washed with phosphate-free 
medium containing dialysed calf serum and then 
incubated in this medium containing l mCi 
[32p]orthophosphate per flask for 15-18 h. All 
subsequent steps were done at 0-4°C. Cells were 
scraped into Earle's balanced saline, cen- 
trifuged, and washed again before suspension 
and dounce homogenization in 1.5 vol of Hepes 
buffer (10mM Hepes, l mM EDTA, 10raM 
NaF, pH 7.35 at 4°C). The homogenate was 
centrifuged at 100,000g for l h, and the clear 
supernatant (minus the floating lipid layer) was 
removed and is referred to as "cytosol". 
Proteolysis and chemical cleavage 
Receptors were digested with proteases before 
adsorption to protein-A Sepharose with 
BuGR2. TPCK-treated trypsin or TLCK- 
treated chymotrypsin solutions were freshly pre- 
pared in Hepes buffer. Proteins in cytosol were 
digested with 100 ktg/ml trypsin or 1/~g/ml chy- 
motrypsin for 1 h at 0°C. To terminate the 
proteolysis, 1 mg/ml soybean trypsin inhibitor 
in Hepes buffer (trypsin digestions) or 
100#g/ml TPCK in methanol (chymotrypsin 
digestions) were added to the mixtures. 
For cleavage with cyanogen bromide, recep- 
tors were first immunoadsorbed to protein A- 
Sepharose, washed (6 x lml) with TEGNT 
buffer (10mM TES, 4raM EDTA, 550raM 
NaC1, 10% w/v glycerol, 0.4% Triton X-100, 
pH 7.6 at 4'C) to remove nonspecifically ad- 
sorbed proteins. The immunoadsorbed proteins 
were then resolved by SDS PAGE, electrophor- 
etically transferred to nitrocellulose membranes, 
and the nitrocellulose strip corresponding to the 
intact 32p-labeled receptor was localized by 
autoradiography of the dried nitrocellulose 
membrane. The strip was then excized with a 
razor blade and put into a microfuge tube with 
100~tg of bovine serum albumin (BSA) and 
800 ktl of 100 mg/ml solution of cyanogen bro- 
mide in 70% formic acid under nitrogen gas and 
mixed overnight at room temperature. The re- 
sultant supernatant was removed, evaporated to 
dryness, and the cleaved proteins in the dried 
supernatant were then resolved using 12% 
SDS-PAGE. The 32p-labeled receptor frag- 
ments were visualized by autoradiography. 
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Incubation with antibodies and adsorption to 
protein A-Sepharose 
Aliquots of untreated or protease-digested 
cytosol were mixed with equal volumes of TEG 
buffer (10mM TES, 50mM NaCI, 4mM 
EDTA, 10% w/v glycerol, pH7.6 at 4°C). 
BuGR2 antibody was added at 2% of the final 
volume. The mixtures were incubated 2-4 h on 
ice and then added to a 50/~l bed volume of 
protein A-Sepharose and mixed at 4°C for 1 h. 
The Sepharose beads were pelleted and washed 
5-8 times by resuspension in TEGNT buffer, 
and the pellet was washed three additional times 
with TEG buffer. The immunoadsorbed pro- 
teins were extracted by boiling the pellet in SDS 
sample buffer plus 10% fl-mercaptoethanol. 
Gel electrophoresis and Western blotting 
SDS-PAGE was performed in 10-12% acryl- 
amide gels according to Laemmli [16]. In Fig. 3, 
a gradient polyacrylamide gel of 5-20% poly- 
acrylamide was used to resolve the protein 
mixture. Gels were cooled to 4°C during electro- 
phoresis. All samples were taken up in 2 × SDS 
sample buffer containing 10% fl-mercap- 
toethanol and boiled. Molecular weight 
standards were myosin, Mr = 205,000, fl-galac- 
tosidase, Mr = 116,000; phosphorylase b, 
Mr=97,000; BSA, Mr=66,000; ovalbumin, 
M; =  45,000; glyceraldehyde-3-phosphate dehy- 
drogenase, M, = 36,000; carbonic anhydrase, 
Mr = 29,000; trypsinogen, Mr = 24,000; trypsin 
inhibitor, M, = 20,000, and 0t-lactalbumin, 
Mr= 14,200. After electrophoresis, proteins 
were transferred to Immobilon-P membranes 
and Western blotted by probing with 1% 
BuGR2 antibody followed by a second incu- 
bation with goat anti-mouse IgG coupled to 
horseradish peroxidase. Autoradiography to 
visualize 32p was performed directly from the 
Western blot. 
RESULTS AND DISCUSSION 
As reported by Danielson et al. [3], the intact 
mouse GR is a 783 amino acid chain with a 
calculated molecular mass of ~ 86 kDa. 
Figure 1 shows a diagram of the mouse GR 
indicating the functional domains and the ex- 
pected pattern of cleavage produced by chy- 
motrypsin and trypsin [17]. Cyanogen bromide 
cleavage of the receptor produces a number of 
receptor fragments, all smaller than 10kDa 
except for one, which is 23.4 kDa in size and 
contains residues 108-324. Hoeck and 
Groner [11] showed that this fragment is heavily 
phosphorylated and it contains all of the GR 
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Fig. I. Localization of phosphorylation sites, cyanogen bromide fragments and proteolytic fragments 
within the mouse GR. The phosphorylation sites identified by Bodwell e t  al.  [12] in the mouse GR are 
indicated in a linear representation of the mouse receptor with placement of steroid- and DNA-binding 
domains as reported by Danielson e t  al. [3]. The location of the chymotryptic 42 kDa and tryptic 15 kDa 
fragments are as reported from fragment sequencing by Carlstedt-Duke e t  al.  [17]. The solid region defines 
the BuGR epitope according to Ruseoni and Yamamoto [18]. The 23 kDa receptor cyanogen bromide 
fragment was identified using the PEPPLOT program from the Wisconsin Genetics Computer Group 
software package on the mouse GR (GENBANK accession number = X04435). The dashed lines below 
the receptor show the major phosphorylated segment predicted by Dalman e t  al.  [10] as well as our 
adjusted prediction taking into account the ~ 12 kDa M, discrepancy lying within the cyanogen bromide 
fragment. 












Fig. 2. The major 32p-labeled cyanogen bromide fragment of 
the mouse GR is ~ 1 2 k D a  larger than the calculated 
molecular weight. WCL2 cells were labeled for 15 h with 
[32P]orthophosphate, and GR were immunopurified from 
cell lysates with BuGR2 antibody. The immunopurified 
32p-labeled receptor was resolved by SDS~PAGE, electro- 
phoretically transferred to nitrocellulose, and the region of 
the nitrocellulose membrane corresponding to the intact 
~ 9 8 k D a  receptor was excized with a razor blade. The 
nitrocellulose strip was then treated overnight with 
cyanogen bromide at room temperature. The resultant 
supernatant was lyophilized, resolved on 10% SDS PAGE, 
and the receptor fragments were visualized by autoradiog- 
raphy. (A) Autoradiographic profile of immunopurified GR 
from 32p-labeled WCL2 cells. (B) Autoradiographic profile 
of CNBR-cleaved receptor showing the 23.4 kDa (calcu- 
lated) receptor fragment migrating at ~ 35 kDa. 
phosphorylation sites subsequently identified by 
Bodwell et al. [12]. 
In the experiment shown in Fig. 2, WCL2 
cells were labeled for roughly a cell generation 
time with [32P]orthophosphate, iysed, and the 
intact GR was immunoadsorbed with BuGR2. 
The immune pellet was washed extensively with 
a buffer containing both detergent and salt to 
remove extraneous proteins. The immunop- 
urified 32p-labeled intact receptor is shown in 
Fig. 2(A) and the cyanogen bromide-cleaved 
receptor fragments obtained from the gel- 
purified intact receptor are shown in Fig. 2(B). 
There is a major 32p-labeled band migrating at 
,-~35 kDa, with the remainder of the labeled 
fragments running at the gel dye front. Of the 
25 cyanogen bromide fragments, all of the rest 
(9.4 kDa or less) are at the dye front. The lack 
of resolvable fragments between the ~35 kDa 
band and the dye front is evidence for cleavage 
to completion in the experiment of Fig. 2, and 
longer cyanogen bromide treatment did not 
yield smaller fragments. To achieve an 
,-~35 kDa fragment extending into the DNA- 
binding domain region, the 23.4 kDa fragment 
would have to be extended through cyanogen 
bromide cleavage sites at residues 324, 339, 344 
and 389 without showing 32p-labeled bands indi- 
cating partial cleavage at any of these sites. 
Thus, we conclude that this ~ 35 kDa fragment 
contains residues 108-324. The ,,~ 12 kDa differ- 
ence between the theoretical molecular weight 
(23.4 kDa) and experimentally observed 
Mr(~35 kDa) of this cyanogen bromide frag- 
ment accounts for most of the difference be- 
tween the theoretical ( ~ 86 kDa) and 
experimental (~98 kDa) values for the intact 
mouse GR. Thus, we propose that this fragment 
of the receptor contains the residues that cause 
anomalous migration of the intact receptor on 
SDS-PAGE. 
Because the mouse GR can be nearly com- 
pletely dephosphorylated without change in Mr 
on SDS-PAGE [10], the anomalous Mr cannot 
be explained on the basis of receptor phos- 
phorylation. Numerous attempts by our lab and 
others have failed to demonstrate a reduction in 
M r by treatment of the GR with glycohydro- 
lases, and it is the impression in the field that the 
GR does not contain carbohydrate moieties. 
Thus, at the moment, the basis for the Mr 
differential is unknown, but its localization to 
residues 108-324 should be taken into account 
when calculations are made from receptor frag- 
ments identified on SDS-PAGE. 
An example of the error that can arise was 
published in a previous study from our lab by 
Dalman et al. [10] in which the location of the 
12 kDa differential was not known and the 
major sites of phosphorylation were predicted 
from proteolytic fragments to lie between 
residues 313 and 369 of the mouse GR. This 
predicted phosphorylated segment would have 
been extended about 110 amino acids toward 
the amino-terminus to yield the adjusted predic- 
tion shown in Fig. 1 had we known that the 
12 kDa differential lay within the cyanogen 
bromide fragment. The adjusted prediction in- 
cludes four of the seven phosphorylated sites 
identified by Bodwell et al. [12] in the mouse GR 
(Fig. 1). These four sites (Ser 212, 220, 234, 315) 
account for ,-~75% of the 32p recovered in the 
seven phosphorylation sites (see Table I in 
Bodwell et al. [12]) and after this adjustment, 
the predictions made by Dalman et al. [10] from 
proteolytic fragments without sequence data 
become much more accurate. 
Five phosphorylated peptides (phosphopep- 
tides 5, 6, 11, 16 and 23) containing 19% of the 
Glucocorticoid receptor phosphorylation 685 
total 32p recovered by Bodwell et  al. [12] were 
not sequenced. Our cyanogen bromide exper- 
iments also reveal small 32p-labeled peptides on 
SDS-PAGE [Fig. 2(B)] suggesting the presence 
of other phosphorylated sites within the recep- 
tor. Both the Pratt and the Groner laboratories 
have previously reported that the tryptic 15 kDa 
fragment containing the DNA binding domain 
(Fig. 1) is phosphorylated in GR isolated from 
mouse L cells [10] and rat hepatoma cells [11]. 
These reports have been challenged by van der 
Weijden Benjamin et al. [19] who concluded 
from a study of GR phosphorylation in cultured 
AtT-20 cells that the 15 kDa phosphorylated 
tryptic fragment is similar in size to the DNA- 
binding tryptic fragment containing the BuGR 
epitope (C375-K505) but is not the DNA- 
binding, BuGR-reactive fragment itself. The 
data of Fig. 3 show that the 15 kDa tryptic 
fragment containing the DNA-binding domain 
of the mouse GR is phosphorylated. 
To determine if the ~ 15 kDa DNA-binding 
domain fragment of the GR is phosphorylated 
in WCL2 cells, we cultured the cells in 
[32p]orthophosphate containing growth medium 
for 15 h, lysed the cells under hypotonic con- 
ditions, and then cleaved receptors in cytosol 
before immunoadsorption to protein A-Sepha- 
rose with BuGR2. The immunoreactive intact 
receptor is shown in lane 3 of Fig. 3(A), while 
lane 3 [Fig. 3(B)] shows [32p]phosphate associ- 
ated with the intact receptor. Lane 1, in A shows 
the 42 kDa chymotryptic immunoreactive frag- 
ment containing the DNA- and steroid-binding 
domains, and as reported for L cell recep- 
tors[10], lane 1, in B shows that the 42Da 
chymotryptic fragment contains radiolabeled 
phosphate. Lane 2, in A shows the immuno- 
reactive 15kDa tryptic receptor fragment 
containing the DNA-binding domain, while 
lane 2, in B, shows the immunoadsorbable 
[32p]phosphate signal in the trypsin-cleaved cy- 
tosol. It is clear that the 15 kDa immunoreactive 
fragment produced from the intact receptor 
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Fig. 3. The 15 kDa tryptic fragment containing DNA-binding domain of the mouse GR is phosphorylated 
after incubation of WCL2 cells in [32p]orthophosphate-containing growth medium. WCL2 cells were 
labeled for 15 h with phosphate-free medium (DMEM) containing [ 32p]orthophosphate. Cell lysates were 
harvested and treated with buffer (lane 3), chymotrypsin (lane 1) or trypsin (lane 2). Receptors were then 
immunopurified from treated lysates with BuGR2 adsorbed to protein A-Sepharose, resolved on a 
grad/ent SDS-polyacrylamide gel and electrophoretically transferred to Immobilon-P membranes. (A) 
Shows an immunohlot with BuGR2 to visualize the intact receptor and receptor fragments, and (B) is 
an autoradiogram of the same immunoblot. The two bands present in all three lanes of the Western blot 
migrating at ~55 and ~25 kDa are the heavy and light chains, respectively, of the BuGR antibody. 
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c o m i g r a t e s  exac t ly  wi th  the  15 k D a  32p-labeled 
r e c e p t o r  f r a g m e n t .  As  this 15 k D a  t ryp t ic  32p-la- 
be led  f r a g m e n t  was  i m m u n o a d s o r b e d ,  it m u s t  
c o n t a i n  the  B u G R  e p i t o p e  a n d  it m u s t  be the  
C 3 7 5 - K 5 0 5  pept ide .  Indeed ,  we have  d e m o n -  
s t ra ted  p r e v i o u s l y  tha t  this B u G R - a d s o r b e d  
15 k D a  f r a g m e n t  is ful ly  c o m p e t e n t  in b ind ing  
D N A  [20]. Thus ,  we m u s t  d i sag ree  wi th  v a n  de r  
W e i j d e n  B e n j a m i n  e t  al.  [19] w h o  c o n c l u d e d  tha t  
the  m o u s e  G R  D N A - b i n d i n g  d o m a i n  is n o t  
p h o s p h o r y l a t e d  in v ivo .  H o w e v e r ,  it is c lear  tha t  
the  15 k D a  t ryp t ic  f r a g m e n t  is n o t  a m a j o r  site 
fo r  p h o s p h o r y l a t i o n ,  as  we e s t ima te  tha t  this 
f r a g m e n t  c o n t a i n s  on ly  ~ 5 %  o f  the  to ta l  r ecep-  
t o r  p h o s p h a t e .  
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